COPART, INC. vs CVS HEALTH CORPORATION, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CPRT and CVS diverge most: on debt / equity, CPRT reads 0.00 and CVS reads 0.74; on net margin, CPRT reads 33.5% and CVS reads 0.7%. The rest of the comparable metrics sit closer together. What CPRT's price implies is a bet that sits within the historical range (whole-company basis). What CVS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CPRT | CVS |
|---|---|---|
| Price | $29.94 | $94.67 |
| Market cap | $28.2B | $121.8B |
| Sector | Retail | Retail |
| Stage | Mature | Mature |
| Implied growth (priced in) | +6.6% | — |
| P/E | 18.7 | 25.0 |
| P/B | 3.22 | 1.52 |
| P/S | 6.08 | 0.29 |
| EV/EBITDA | 15.1 | 13.3 |
| Revenue growth | +1.1% | +7.3% |
| Operating margin | 37.5% | 4.4% |
| Net margin | 33.5% | 0.7% |
| Return on equity | 17.7% | 3.7% |
| Return on assets | 16.1% | 1.2% |
| Return on invested capital | 15.4% | 4.5% |
| FCF yield | 4.7% | 9.7% |
| Dividend yield | — | 2.8% |
| Debt / equity | 0.00 | 0.74 |
| Current ratio | 7.61 | 0.87 |
| Altman Z (solvency) | 8.31 | 2.42 |
| Piotroski F (quality) | 8 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.